Global Health Security Research & Development Programme.
- Funded by Foreign, Commonwealth & Development Office (FCDO)
- Total publications:0 publications
Grant number: GB-GOV-1-301542-402
Grant search
Key facts
Disease
Ebola, mpox, CholeraStart & end year
20232027Known Financial Commitments (USD)
$2,573,606.26Funder
Foreign, Commonwealth & Development Office (FCDO)Research Location
NorwayLead Research Institution
Coalition for Epidemic Preparedness Innovations (CEPI)Research Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnosticsResearch Subcategory
DiagnosticsSpecial Interest Tags
N/AStudy Type
UnspecifiedClinical Trial Details
N/ABroad Policy Alignment
PendingAge Group
Not ApplicableVulnerable Population
Not applicableOccupations of Interest
Not applicableMpox Research Priorities
N/AMpox Research Sub Priorities
N/A
Abstract
General: This project relates to the programme funded staff supporting delivery of the overall programme. They provide specialist technical and programme support expertise to ensure the programme funds high quality research to help low and middle-income countries prepare/prevent/respond to health crises. The overall project is supporting research to produce evidence and develop new technologies (e.g. vaccines, diagnostics, and treatments) to tackle emerging and epidemic disease threats (such as Ebola, Mpox and Cholera) in low- and middle-income countries. This project will help ensure the overall programme delivers on its objective to develop new tools which are affordable and accessible in the poorest countries, especially in Sub Saharan Africa.; General: This project relates to the programme funded staff supporting delivery of the overall programme. They provide specialist technical and programme support expertise to ensure the programme funds high quality research to help low and middle-income countries prepare/prevent/respond to health crises. The overall project is supporting research to produce evidence and develop new technologies (e.g. vaccines, diagnostics, and treatments) to tackle emerging and epidemic disease threats (such as Ebola, Mpox and Cholera) in low- and middle-income countries. This project will help ensure the overall programme delivers on its objective to develop new tools which are affordable and accessible in the poorest countries, especially in Sub Saharan Africa.